Article
Glucocorticoids induce osteoporosis mediated by glucocorticoid receptor-dependent and -independent pathways.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 May 2020
Jiang Yu, Lu Yajun, Jiang Xu, Hu Jiawei, Li Rong, Liu Yun, Zhu Guoxing, Rong Xiaoxu
Abstract excerpt
Clinically, glucocorticoids (GCs) are widely used to treat inflammation-related diseases; however, their long-term use causes side effects, such as osteoporosis and predisposition to bone fractures, known as glucocorticoid-induced osteoporosis (GIOP). Nr3c1 is the major glucocorticoid receptor, and its downstream signaling pathway is involved in regulating various intracellular physiological processes, including...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
